Fibroblast growth factor-saporin mitotoxin

Drug Profile

Fibroblast growth factor-saporin mitotoxin

Alternative Names: FGF2-SAP; Fibroblast growth factor-saporin; Pantarin

Latest Information Update: 03 Jan 2001

Price : $50

At a glance

  • Originator Selective Genetics (CEASED)
  • Class Anti-ischaemics; Antineoplastics; Growth factors; Vascular disorder therapies
  • Mechanism of Action Protein synthesis inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Cancer; Eye disorders; Ischaemic heart disorders

Most Recent Events

  • 03 Jan 2001 Discontinued-Preclinical for Eye disorders in USA (Unknown route)
  • 03 Jan 2001 Discontinued-Preclinical for Ischaemic heart disorders in USA (Unknown route)
  • 03 Jan 2001 Discontinued-Preclinical for Cancer in USA (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top